Innovative biopharmaceutical company specializing in blood product replacement therapy, Tenomaibo (688806.SH) plans to publicly issue 69.08 million shares.
Zh tng Cijng APP Xn, ti nu mi b (688806.SH) pl zho g yxing sh, gngs n gngki fxng gpio 6908.19 wn g, zhn gngs fxng hu zng gbn de bl wi 15%. Bnc fxng zhng, chsh zhnl pishu fxng shling wi 1036.23 wn g, zhn bnc fxng shling 15%. Bnc fxng chb xnji rq wi 2026 nin 7 yu 7 r, shngu rq wi 2026 nin 7 yu 10 r.
Latest

